211 related articles for article (PubMed ID: 8333253)
21. Transplantation of embryonic dopamine neurons for severe Parkinson's disease.
Freed CR; Greene PE; Breeze RE; Tsai WY; DuMouchel W; Kao R; Dillon S; Winfield H; Culver S; Trojanowski JQ; Eidelberg D; Fahn S
N Engl J Med; 2001 Mar; 344(10):710-9. PubMed ID: 11236774
[TBL] [Abstract][Full Text] [Related]
22. Fetal brain grafts and Parkinson's disease.
Science; 1990 Dec; 250(4986):1434-5. PubMed ID: 2255915
[No Abstract] [Full Text] [Related]
23. Ontogenesis of embryonic porcine ventral mesencephalon in the perspective of its potential use as a xenograft in Parkinson's disease.
Molenaar GJ; Hogenesch RI; Sprengers ME; Staal MJ
J Comp Neurol; 1997 May; 382(1):19-28. PubMed ID: 9136809
[TBL] [Abstract][Full Text] [Related]
24. [18F]-6-L-fluorodopa PET studies of graft and host dopaminergic function following fetal mesencephalic transplantation.
Sawle GV
Adv Neurol; 1993; 60():715-20. PubMed ID: 8420216
[No Abstract] [Full Text] [Related]
25. Evidence for target-specific outgrowth from subpopulations of grafted human dopamine neurons.
Strömberg I; Törnqvist N; Johansson S; Bygdeman M; Almqvist PM
Microsc Res Tech; 2001 Sep; 54(5):287-97. PubMed ID: 11514985
[TBL] [Abstract][Full Text] [Related]
26. Outcome following intrastriatal fetal mesencephalic grafts for Parkinson's patients is directly related to the volume of grafted tissue.
Kopyov OV; Jacques DS; Lieberman A; Duma CM; Rogers RL
Exp Neurol; 1997 Aug; 146(2):536-45. PubMed ID: 9270065
[TBL] [Abstract][Full Text] [Related]
27. Short- and long-term survival and function of unilateral intrastriatal dopaminergic grafts in Parkinson's disease.
Wenning GK; Odin P; Morrish P; Rehncrona S; Widner H; Brundin P; Rothwell JC; Brown R; Gustavii B; Hagell P; Jahanshahi M; Sawle G; Björklund A; Brooks DJ; Marsden CD; Quinn NP; Lindvall O
Ann Neurol; 1997 Jul; 42(1):95-107. PubMed ID: 9225690
[TBL] [Abstract][Full Text] [Related]
28. Mesencephalic human neural progenitor cells transplanted into the neonatal hemiparkinsonian rat striatum differentiate into neurons and improve motor behaviour.
Hovakimyan M; Haas SJ; Schmitt O; Gerber B; Wree A; Andressen C
J Anat; 2006 Dec; 209(6):721-32. PubMed ID: 17118060
[TBL] [Abstract][Full Text] [Related]
29. Transplants in Parkinson's disease.
Lindvall O
Eur Neurol; 1991; 31 Suppl 1():17-27. PubMed ID: 1855521
[TBL] [Abstract][Full Text] [Related]
30. Interference with anoikis-induced cell death of dopamine neurons: implications for augmenting embryonic graft survival in a rat model of Parkinson's disease.
Marchionini DM; Collier TJ; Camargo M; McGuire S; Pitzer M; Sortwell CE
J Comp Neurol; 2003 Sep; 464(2):172-9. PubMed ID: 12898610
[TBL] [Abstract][Full Text] [Related]
31. Restoration of synaptic plasticity in the host striatum: can transplants make it?
Rylander D
Neuroreport; 2013 Dec; 24(18):1016-8. PubMed ID: 24152765
[TBL] [Abstract][Full Text] [Related]
32. Neural implants and recovery of function: human work.
Hitchcock E
Adv Exp Med Biol; 1992; 325():67-78. PubMed ID: 1337822
[No Abstract] [Full Text] [Related]
33. [Neuronal transplantation in animal models of Parkinson disease: in vivo voltammetry, tissue cryopreservation and immunology].
Sautter J; Kupsch A; Oertel WH; Earl CD
Zentralbl Neurochir; 1995; 56(4):161-7. PubMed ID: 8571694
[TBL] [Abstract][Full Text] [Related]
34. Delta opioid peptide augments functional effects and intrastriatal graft survival of rat fetal ventral mesencephalic cells.
Borlongan CV; Su TP; Wang Y
Cell Transplant; 2001; 10(1):53-8. PubMed ID: 11294472
[TBL] [Abstract][Full Text] [Related]
35. Cellular distribution of the NMDA receptor subunit NMDAR1 in fetal ventral mesencephalon transplants in the dopamine-depleted striatum of a rat.
Todaka K; Ishida Y; Hashiguchi H; Nishimori T; Mitsuyama Y
Exp Neurol; 1999 Dec; 160(2):394-401. PubMed ID: 10619556
[TBL] [Abstract][Full Text] [Related]
36. Can human fetal cortical brain tissue transplant (up to 20 weeks) sustain its metabolic and oxygen requirements in a heterotopic site outside the brain? A study of 12 volunteers with Parkinson's disease.
Bhattacharya N; Chhetri MK; Mukherjee KL; Ghosh AB; Samanta BK; Mitra R; Bhattacharya M; Bhattacharya S; Bandopadhyaya T
Clin Exp Obstet Gynecol; 2002; 29(4):259-66. PubMed ID: 12635741
[TBL] [Abstract][Full Text] [Related]
37. Core Assessment Program for Intracerebral Transplantation in Huntington's Disease (CAPIT-HD).
Quinn N; Brown R; Craufurd D; Goldman S; Hodges J; Kieburtz K; Lindvall O; MacMillan J; Roos R
Mov Disord; 1996 Mar; 11(2):143-50. PubMed ID: 8684383
[TBL] [Abstract][Full Text] [Related]
38. Eighteen-month course of two patients with grafts of fetal dopamine neurons for severe Parkinson's disease.
Hoffer BJ; Leenders KL; Young D; Gerhardt G; Zerbe GO; Bygdeman M; Seiger A; Olson L; Strömberg I; Freedman R
Exp Neurol; 1992 Dec; 118(3):243-52. PubMed ID: 1306484
[TBL] [Abstract][Full Text] [Related]
39. [Intraparenchymal and intraventricular transplantation of fetal substantia nigra cell suspension in rat model of Parkinson's disease].
Yang H; Zhang K; Cai W
Zhonghua Wai Ke Za Zhi; 1997 Jan; 35(1):19-21. PubMed ID: 10374501
[TBL] [Abstract][Full Text] [Related]
40. Regression of parkinsonian fetal ventral mesencephalon grafts upon withdrawal of cyclosporine A immunosuppression. The CPH Neural Transplantation Group.
Lopez-Lozano JJ; Bravo G; Brera B; Dargallo J; Salmean J; Uria J; Insausti J; Martinez R; Sanchez P; de la Torre C; Moreno R
Transplant Proc; 1997; 29(1-2):977-80. PubMed ID: 9123614
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
